Paul Kornberg, MD
Pediatric Rehabilitation Medicine · Tampa, FLNPI 1710943451
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 25.6% of the total.
Across 45 payments — averaging $22.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$261
- Merz Pharmaceuticals, LLC$207
- Amneal Pharmaceuticals LLC$134
- Saol Therapeutics Inc.$109
- Piramal Critical Care$79
- Abbott$37
- plus $190 from 9 others
What the payments were for
- Food & beverage$1,017100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 13 | $261 |
| Merz Pharmaceuticals, LLC | 9 | $207 |
| Amneal Pharmaceuticals LLC | 6 | $134 |
| Saol Therapeutics Inc. | 2 | $109 |
| Piramal Critical Care | 3 | $79 |
| Abbott | 2 | $37 |
| Medtronic | 2 | $34 |
| Boston Scientific | 1 | $31 |
| MDD US Operations, LLC | 1 | $25 |
| Merz North America, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Coloplast | 1 | $19 |
| ABC Home Medical Supply, Inc. | 1 | $17 |
| Microtransponder, Inc. | 1 | $14 |
| Ipsen Biopharmaceuticals, Inc | 1 | $12 |
How this compares
Too few pediatric rehabilitation medicine providers in Floridato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Baclofen | 66 | $1,467 |
| Tizanidine Hcl | 36 | $264 |
| Gabapentin | 19 | $97 |
| Trazodone Hcl | 11 | $93 |
Paid to pharmacies, not to this prescriber.
Other pediatric rehabilitation medicine in Tampa
- James ChinarianSt Petersburg$6K
- Joslyn GoberMiami$2K
- Coral Candelario-VelazquezOrlando$267
- Edwin Cruz-ZenoOrlando$253
- Dennis HartHollywood$242
- Sarah GibsonOrlando$112
- Andrew RiveraLakeland$66
- Rachel LorenzoNew Port Richey$47
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.